1. Home
  2. MTRN vs VERA Comparison

MTRN vs VERA Comparison

Compare MTRN & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MTRN
  • VERA
  • Stock Information
  • Founded
  • MTRN 1931
  • VERA 2016
  • Country
  • MTRN United States
  • VERA United States
  • Employees
  • MTRN N/A
  • VERA 82
  • Industry
  • MTRN Industrial Specialties
  • VERA Biotechnology: Pharmaceutical Preparations
  • Sector
  • MTRN Industrials
  • VERA Health Care
  • Exchange
  • MTRN Nasdaq
  • VERA Nasdaq
  • Market Cap
  • MTRN 2.1B
  • VERA 1.8B
  • IPO Year
  • MTRN N/A
  • VERA 2021
  • Fundamental
  • Price
  • MTRN $95.39
  • VERA $28.58
  • Analyst Decision
  • MTRN Strong Buy
  • VERA Buy
  • Analyst Count
  • MTRN 2
  • VERA 8
  • Target Price
  • MTRN $143.50
  • VERA $66.38
  • AVG Volume (30 Days)
  • MTRN 90.3K
  • VERA 1.0M
  • Earning Date
  • MTRN 02-19-2025
  • VERA 03-19-2025
  • Dividend Yield
  • MTRN 0.56%
  • VERA N/A
  • EPS Growth
  • MTRN N/A
  • VERA N/A
  • EPS
  • MTRN 0.28
  • VERA N/A
  • Revenue
  • MTRN $1,684,739,000.00
  • VERA N/A
  • Revenue This Year
  • MTRN $2.99
  • VERA N/A
  • Revenue Next Year
  • MTRN $5.66
  • VERA N/A
  • P/E Ratio
  • MTRN $337.05
  • VERA N/A
  • Revenue Growth
  • MTRN 1.17
  • VERA N/A
  • 52 Week Low
  • MTRN $93.20
  • VERA $25.99
  • 52 Week High
  • MTRN $139.21
  • VERA $51.61
  • Technical
  • Relative Strength Index (RSI)
  • MTRN 40.94
  • VERA 29.57
  • Support Level
  • MTRN $96.39
  • VERA $25.99
  • Resistance Level
  • MTRN $106.57
  • VERA $34.79
  • Average True Range (ATR)
  • MTRN 3.44
  • VERA 2.15
  • MACD
  • MTRN -0.11
  • VERA -0.56
  • Stochastic Oscillator
  • MTRN 0.36
  • VERA 20.05

About MTRN Materion Corporation

Materion Corp specializes in the development of specialty engineered alloy systems, inorganic chemicals and powders, precious and non-precious metals, beryllium and beryllium composites, and precision filters and optical coatings. The company operates in four reportable segments: Performance Materials, Electronic Materials, Precision Optics, and Others. The majority of revenue is derived from Electronic Materials which produces chemicals, microelectronics packaging, precious metal, non-precious metal, and specialty metal products, including vapor deposition targets, frame lid assemblies, clad and precious metal pre-forms. The Performance Materials segment provides engineered solutions comprised of beryllium and non-beryllium-containing alloy systems and custom-engineered parts.

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

Share on Social Networks: